304840 — Peoplebio Share Price
0.000.00%
Last trade - 00:00- KR₩57bn
- KR₩56bn
- KR₩4bn
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 3.05 | ||
| Price to Tang. Book | 3.62 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 12.88 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -67.67% | ||
| Return on Equity | -141.79% | ||
| Operating Margin | -365.44% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | KR₩m | 895.04 | 507.85 | 577.08 | 4,444.83 | 4,452.86 | n/a | n/a | 144.19% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
PeopleBio Co Ltd is a Korea-based company mainly engaged in the manufacture and sale of medical supplies. The Company's main products include oligomerized beta-amyloid (OAβ) test systems, and others. The Company’s multimer detection system (MDS) is sandwich assay using capturing antibodies and epitope-overlapping detection antibodies for the detection of only oligomers or multimers from monomers in protein-misfolding diseases. The Company sells its products in domestic and overseas markets.
Directors
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- September 9th, 2002
- Public Since
- October 19th, 2020
- No. of Shareholders
- 27,651
- No. of Employees
- 36
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- Korea Exchange - KOSDAQ
- Shares in Issue
- 21,089,464
- Address
- 6F, Seongnam, 13487
- Web
- http://www.peoplebio.net/
- Phone
- +82 315267825
- Auditors
- Dasan Accounting Corp.
Upcoming Events for 304840
Q2 2024 PeopleBio Inc Earnings Release
Similar to 304840
Access Bio
Korea Exchange - KOSDAQ
Aligned Genetics
Korea Exchange - KOSDAQ
Angel Robotics Co
Korea Exchange - KOSDAQ
Asta Co
Korea Exchange - KOSDAQ
Biodyne Co
Korea Exchange - KOSDAQ
FAQ
What is the Peoplebio share price?
As of Today at 07:17 UTC, shares in Peoplebio are trading at KR₩2,720. This share price information is delayed by 15 minutes.
How has the Peoplebio share price performed this year?
Shares in Peoplebio last closed at KR₩2,720 and the price had moved by -67.45% over the past 365 days. In terms of relative price strength the Peoplebio share price has underperformed the FTSE Developed Asia Pacific Index by -67.7% over the past year.
What are the analyst and broker recommendations for Peoplebio?
There is no consensus recommendation for this security.
What is the Peoplebio dividend yield?
Peoplebio does not currently pay a dividend.
Does Peoplebio pay a dividend?
Peoplebio does not currently pay a dividend.
When does Peoplebio next pay dividends?
Peoplebio does not currently pay a dividend.
How do I buy Peoplebio shares?
To buy shares in Peoplebio you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Peoplebio?
As of the previous close price of KR₩2,720, shares in Peoplebio had a market capitalisation of KR₩57bn.
Where are Peoplebio shares listed?
Here are the trading details for Peoplebio:
- Country of listing: Korea, Republic of
- Exchange: KOE
- Ticker Symbol: 304840
What kind of share is Peoplebio?
Based on an overall assessment of its quality, value and momentum Peoplebio is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Peoplebio share price forecast for 2024?
We could not find analyst target price data for this security.
What is the trend in the Peoplebio share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Peoplebio. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -24.41%.
As of the last closing price of KR₩2,720, shares in Peoplebio were trading -35.83% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Peoplebio PE Ratio?
The Peoplebio PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at KR₩2,720.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Peoplebio?
We do not have data on Peoplebio's directors